Table 2. Associations of CSVD image markers with initial stroke severity and outcomes within 90 days.
| CSVD image markers | NIHSS§ | mRS¶ | Stroke recurrence | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |||
| Fazekas | ||||||||
| 0–2 | 1 | 1 | 1 | |||||
| 3–4 | 1.12 (0.82–1.74) | 0.35 | 1.49 (0.86–2.57) | 0.16 | 1.16 (0.65–2.06) | 0.61 | ||
| 5–6 | 2.10 (1.26–3.48) | 0.004 | 0.84 (0.40–1.71) | 0.62 | 0.65 (0.28–1.48) | 0.30 | ||
| SDWMHs† | 1.66 (1.15–2.40) | 0.007 | 0.81 (0.48–1.37) | 0.43 | 0.68 (0.68–1.22) | 0.19 | ||
| PVWMHs‡ | 1.47 (1.02–2.10) | 0.04 | 1.35 (0.79–2.32) | 0.27 | 0.99 (0.55–1.78) | 0.98 | ||
†, SDWMHs: Fazekas score 2-3 vs. 0-1 in the subcortical area; ‡, PVWMHs: Fazekas scale 2-3 vs. 0-1 in the periventrcular area; §, NIHSS score 2-3; ¶, mRS score 2-6.